Company intelligence / Profile preview

Sotret

Mumbai, Maharashtra, India

Ownership: Private
Employees: ~41000
Development stage: Other

Overview

Sun Pharmaceutical Industries is a leading global specialty generic pharmaceutical company headquartered in Mumbai, India. The company manufactures and markets a vast portfolio of pharmaceutical formulations, including the popular acne medication Sotret (isotretinoin), which was originally part of the Ranbaxy Laboratories portfolio prior to its acquisition by Sun Pharma. Sun Pharma provides high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries. Its business encompasses generics, branded generics, specialty products, and active pharmaceutical ingredients (APIs) across various therapeutic areas such as dermatology, psychiatry, neurology, and cardiology.

Therapeutic areas: OncologyDermatology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Merck & Co.AstraZeneca

Beyond the preview

Go deeper on Sotret.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sotret.

Explore the full profile